Yuhi Hasebe
Overview
Explore the profile of Yuhi Hasebe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
169
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hayashi H, Nochioka K, Nakano M, Shiroto T, Hasebe Y, Noda T, et al.
Circ J
. 2025 Jan;
PMID: 39828331
Background: Although sudden cardiac death (SCD) generally occurs more frequently in men than in women, there are limited data on sex differences in SCD in patients with chronic heart failure...
2.
Nochioka K, Yasuda S, Shiroto T, Yamamoto S, Sato H, Hasebe Y, et al.
ESC Heart Fail
. 2024 Nov;
PMID: 39543917
Background: There are limited data on the efficacy of smartphone-based personal health records (PHRs) in patients with cardiovascular disease. This study aimed to examine the processes, outcomes and challenges associated...
3.
Sato H, Noda T, Ito T, Yamamoto N, Chiba T, Hasebe Y, et al.
Circ J
. 2024 Nov;
89(2):224-233.
PMID: 39523009
Background: Although the MADIT-ICD benefit score (MBS) helps select suitable implantable cardioverter defibrillator (ICD) candidates, optimal indicators for cardiac resynchronization therapy (CRT) remain uncertain. Evaluating the applicability of the MBS...
4.
Ito T, Noda T, Nochioka K, Shiroto T, Yamamoto N, Sato H, et al.
Europace
. 2024 Aug;
26(9).
PMID: 39150084
Aims: Atrial fibrillation (AF) frequently coexists with heart failure with preserved ejection fraction (HFpEF), and clinical outcomes of patients with AF vary depending on its subtype. While AF progression characterized...
5.
Maeda S, Kawabata M, Kamata T, Hasebe Y, Liang J, Casado Arroyo R, et al.
J Interv Card Electrophysiol
. 2024 Jul;
67(8):1753-1754.
PMID: 38977620
No abstract available.
6.
Nakano M, Yasuda S, Hasebe Y, Nochioka K, Fukuda K, Takahashi J, et al.
Int J Cardiol Heart Vasc
. 2024 Jun;
52:101387.
PMID: 38854744
No abstract available.
7.
Yamamoto N, Noda T, Nakano M, Ito T, Sato H, Hayashi H, et al.
Heart Rhythm
. 2024 Feb;
21(6):855-862.
PMID: 38367890
Background: Cardiac resynchronization therapy (CRT) is effective for patients with heart failure with QRS duration (QRSd) ≥150 ms. However, its beneficial effect seems to be limited for those with "mid-range"...
8.
Shindo T, Ito K, Ogata T, Kurosawa R, Eguchi K, Kagaya Y, et al.
PLoS One
. 2023 Jun;
18(6):e0287714.
PMID: 37352324
Background: Despite the advances in the treatment of cardiovascular diseases, effective treatment remains to be established to improve the quality of life and prognosis of patients with chronic coronary syndromes....
9.
Godo S, Hasebe Y, Takahashi J, Shimokawa H, Yasuda S
Eur Heart J Case Rep
. 2022 Jul;
6(7):ytac291.
PMID: 35865225
No abstract available.
10.
Hayashi H, Yasuda S, Nakano M, Sakata Y, Nochioka K, Shiroto T, et al.
Circ Rep
. 2022 Jul;
4(6):264-273.
PMID: 35774073
Although cardiac resynchronization therapy (CRT) is effective for patients with chronic heart failure (CHF) with reduced left ventricular ejection fraction and wide QRS (≥120 ms), data on the use of...